Mediating Effects of Pain Interference on the Relationships Between Pain Intensity and Probable Major Depression Among Participants With Spinal Cord Injury
Chao Li,Nicole D DiPiro,Jillian M R Clark,James S Krause,Nicole D. DiPiro,Jillian M.R. Clark,James S. Krause
DOI: https://doi.org/10.1016/j.apmr.2021.04.011
IF: 4.06
2022-04-01
Archives of Physical Medicine and Rehabilitation
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>To evaluate whether pain interference mediates the relationship between pain intensity and possible major depression (PMD) among persons with spinal cord injury (SCI), accounting for differences in the frequency of prescription medication use and resilience.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Design</h3><p>Cross-sectional analysis using self-report assessment.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Setting</h3><p>Medical university in the Southeastern United States.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Participants</h3><p>There were a total of 4,670 participants, all of whom had traumatic SCI of at least 1-year duration, identified from the Southeastern Regional SCI Model System and two state-based surveillance systems.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Interventions</h3><p>Not applicable.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Main Outcome Measure(s)</h3><p>The Patient Health Questionnaire-9 was used to define PMD. Covariates included demographic and injury characteristics, pain severity, pain interference and resilience. Separate sets of multi-stage logistic regression analyses were conducted for three levels of prescription pain medication use (daily, occasional/weekly, and none).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Pain intensity was related to a greater risk of PMD (odds ratios (OR) <sub>daily pain medication user</sub>=1.28, 95 % confidence interval (CI): 1.21-1.35; OR <sub>occasional/weekly pain medication user</sub>=1.26, 95% CI:1.16-1.36; OR <sub>non-pain medication user</sub>=1.44, 95% CI:1.33-1.56), but this relationship disappeared after consideration of pain interference (OR <sub>daily pain medication user</sub>=0.97, 95% CI: 0.90-1.04; OR <sub>occasional/weekly pain medication user</sub>=0.94, 95% CI:0.84-1.05; OR <sub>non-pain medication user</sub>=1.07, 95% CI:0.95-1.20), which indicates pain interference was a mediator between pain intensity and PMD and there was no direct relationship between pain intensity and PMD. Resilience was protective of PMD in each model, but was not a mediator.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion(s)</h3><p>Although pain intensity was associated with PMD, the relationship was mediated by pain interference. Resilience was an important protective factor. Therefore, clinicians should assess pain interference when screening for PMD and direct treatment at reducing pain interference. Building resilience may further reduce the risk of PMD.</p>
rehabilitation,sport sciences